Thursday, 18 October 2018

Reuters Health Report: Merck, Pfizer combo treatment meets main goals of kidney cancer trial

Reuters.com Newsletter

Merck, Pfizer combo treatment meets main goals of kidney cancer trial

Merck & Co said on Thursday a combination treatment of its cancer drug Keytruda and Pfizer Inc's Inlyta met the main goals of a late-stage study in patients with the most common form of kidney cancer.

Scottish government identifies case of mad cow disease

Scotland's government said on Thursday that a case of bovine spongiform encephalopathy (BSE), or mad cow disease, had been discovered on a farm in Aberdeenshire.

McConnell says Senate Republicans might revisit Obamacare repeal

Republicans could try again to repeal Obamacare if they win enough seats in U.S. elections next month, Senate Republican Leader Mitch McConnell said on Wednesday, calling a failed 2017 push to repeal the healthcare law a "disappointment."

Congo's Ebola outbreak to worsen without stepped-up response: WHO committee

The Ebola outbreak in Democratic Republic of Congo is likely to worsen significantly unless the response to it is stepped up, an emergency committee of experts convened by the World Health Organization said on Wednesday.

IUD risk for new mothers depends on timing

(Reuters Health) - New mothers who want intrauterine devices (IUDs) for long-acting contraception after giving birth should know the risk of the implant being expelled is tied to how soon after delivery it is inserted, researchers say.

Daily time with controlled blood sugar tied to risk of diabetic eye disease

(Reuters Health) - For people with diabetes, the chance of developing eye damage that can lead to blindness may depend on how many hours per day they can keep their blood sugar levels under control, a Chinese study suggests.

HIV prevention drugs could dramatically cut new infections

(Reuters Health) - An HIV-prevention drug pill, dubbed PrEP, dramatically reduced new infections in a large group of high risk gay men, Australian researchers report.

Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

Express Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

Express Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

Exclusive: Science journal to withdraw chronic fatigue review amid patient activist complaints

A respected science journal is to withdraw a much-cited review of evidence on an illness known as chronic fatigue syndrome (CFS) amid fierce criticism and pressure from activists and patients.

Poverty tied to worse heart health among U.S. teens

(Reuters Health) - Adolescents from low-income families are more likely than their affluent peers to have risk factors for cardiovascular disease like obesity, inactivity, poor nutrition and tobacco use, a U.S. study suggests.

Related Videos

INSIGHT: Leaping off a bridge in Sochi festival

VERBATIM: Pope compares abortion to hiring hitman

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS